[Ip-health] Alan Story: A patented Covid-19 vaccine could price out millions | Green World
pfehlner at revisiontx.com
Sun May 10 17:19:13 PDT 2020
If vaccine funders like Gates Foundation, the EU consortium, and others (I’m not expecting the USG to support access over profit, but you never know) insist on contributing the fruit of funded research to the COVID-19 technology pool, and the pool organization requires re-contribution as a condition for accessing the pool — that is, a Linux-style open innovation platform — the pool could be hugely successful. If the funders don’t care, the pool will achieve a shadow of its potential.
Sent from my iPhone
> On May 7, 2020, at 10:59 AM, James Love <james.love at keionline.org> wrote:
> Alan story has a long piece on the patents issues related to vaccines. One
> thing that sticks out is a telling quote from Dick Wilder at CEPI on the
> issue of open licensing. This is pretty significant, given the amount of
> money from government and private donors to CEPI for vaccine development.
> The Costa Rica proposal is “not effective and not necessary”, Richard
> Wilder, general legal counsel of the Coalition for Epidemic Preparedness
> Innovations (CEPI) told Green World last week in an exclusive interview.
> Wilder, who is also CEPI’s director of business development, said
> pharmaceutical companies, biotech firms and academic labs will refuse to
> share their vaccine technologies and scientific processes and there is
> “simply no time now” to do anything different than usual.
> This then becomes a key question of the hour: is the need for a Covid-19
> vaccine, its manufacture and its distribution now so great that “business
> as usual”, as Ellen ‘t Hoen puts it, is a non-starter? And will governments
> require patent holders to share?
> James Love. Knowledge Ecology International
> U.S. Mobile +1.202.361.3040
> U.S. office phone +1.202.332.2670
> http://www.keionline.org <http://www.keionline.org/donate.html>
> Ip-health mailing list
> Ip-health at lists.keionline.org
More information about the Ip-health